Skip to main content
Premium Trial:

Request an Annual Quote

New Products: NanoString's nCounter Elements General Purpose Reagents

Premium

NanoString Technologies this week announced the availability of nCounter Elements, general purpose reagents developed for translational research and clinical laboratories.

The reagents rely on the company's digital molecular barcoding chemistry. Users can use the reagents to assemble their own customized assays using standard sets of barcodes provided by NanoString and probes that they can purchase independently from an oligonucleotide manufacturer, the company said.

The reagents have also been registered with the US Food and Drug Administrations as general purpose reagents, and are available for use in developing laboratory-developed tests.

NanoString said that customers in its early access program will receive the first shipments of nCounter Elements GPRs in the third quarter. They will be able to provide feedback prior to full commercialization.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.